Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
The Pediatric Infectious Disease Journal|November 7, 2007
A new combination haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infantsDavid Pace, Matthew Snape, Sharon Westcar, et al.
Vaccine|December 29, 2016
Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancyDavid Pace, Ameneh Khatami, Simon Attard-Montalto, et al.
Obesity Surgery|November 9, 2017
Preoperative and Postoperative Assessments of Biochemical Parameters in Patients with Severe Obesity Undergoing Laparoscopic Sleeve GastrectomyDeborah M Gregory, Laurie K Twells, Kendra K Lester, et al.
BMC Health Services Research|October 30, 2016
The Newfoundland and Labrador Bariatric Surgery Cohort Study: Rational and Study ProtocolLaurie K Twells, Deborah M Gregory, William K Midodzi, et al.
American Journal of Surgery|March 28, 2012
The script concordance test as a measure of clinical reasoning: a national validation studyThamer Nouh, Marylise Boutros, Robert Gagnon, et al.
Frontiers in Immunology|September 25, 2023
Neuroinflammation, autoinflammation, splenomegaly and anemia caused by bi-allelic mutations in IRAK4Samantha Cooray, Fiona Price-Kuehne, Ying Hong, et al.
Human Vaccines & Immunotherapeutics|June 4, 2015
Meningococcal serogroup Y disease in Europe: Continuation of high importance in some European regions in 2013Michael Bröker, Stéphane Emonet, Cecilia Fazio, et al.
Plos One|December 5, 2013
Occurrence of nodular lymphocyte-predominant hodgkin lymphoma in hermansky-pudlak type 2 syndrome is associated to natural killer and natural killer T cell defectsLuisa Lorenzi, Giovanna Tabellini, William Vermi, et al.
JAMA|January 10, 2008
Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trialMatthew D Snape, Kirsten P Perrett, Karen J Ford, et al.
BMJ (Clinical Research Ed.)|April 3, 2015
Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trialDavid Pace, Ameneh Khatami, Jennifer McKenna, et al.
Pageof 8